SILVER-LAKE/SILAE
8.7.2020 07:02:07 CEST | Business Wire | Press release
Silae, a specialist provider of cloud-based payroll and HR software for the French market, and Silver Lake, a global technology investment firm, today announced that Silver Lake is to acquire 100% of Silae from its founding shareholders, who intend to remain involved in the business.
Jean-Paul Bagou, Michel Delolme, Didier Fléchet, Philippe Marty and Daniel Mayet, co-founders of Silae, said: “As a founder group, we are extremely proud of what Silae has achieved over the past decade. Together with our exceptional and talented employees and partners, we have built a highly successful company and laid a strong foundation for the future by developing a suite of leading SaaS Payroll and HR software products and continuously improving our customer service. As Silae begins an exciting new chapter of product innovation and growth, we are thrilled to partner with Silver Lake, a world-class technology investor with deep software industry expertise and value creation capabilities. This investment marks an acceleration point for our company, employees, customers and partners, as we gain further strength to reinforce our current position in the market while continuing to develop new innovative products and services.”
Christian Lucas, Co-Head of Silver Lake EMEA said: “We want to thank all five founders of Silae for entrusting us with the very special company that they have built over the past decade. We are highly impressed by how, together with employees, they have built Silae into an outstanding and fast-growing company, with an established track record of providing best-in-class SaaS solutions in the payroll and HR segments. Investing in high-growth, innovative, founder-led technology businesses is at the core of Silver Lake’s DNA and it is a privilege to partner with the current team. As the company enters a new phase of value creation, we look forward to continuing working with them and we intend to invest in the company’s continued success to further strengthen its technology platform, as well as its products and services offered to its current and future clients.”
Founded in 2010 and headquartered in Aix-en-Provence, France, Silae is a specialist provider of fully cloud-based Payroll and HR software, offering a range of SaaS solutions and cloud services to simplify and automate complex processes for more than 550,000 businesses in France in close partnership with a wide network of CPAs and HR outsourcing specialists. Silae’s proprietary and highly automated core software platform Silaexpert provides unique scalability to its partner network, enabling substantial efficiency increases along the HR process chain and attracting a rapidly growing number of customers and partners. Silae has established a strong trajectory of growth and profitability increases, more than doubling its revenue and tripling its EBITDA over the past two years. In 2020, Silae is on track to reach a further major milestone on its growth path by becoming the trusted partner for more than 4 million employees in France who will have their payroll slips processed by the company’s solutions.
Silver Lake is planning to invest in Silae and support it in its next phase of development as the company is set to further accelerate its growth, through innovative new products such as its employee engagement solution PaiePilote, as well as to build on its strong technology expertise to extend its product offering while keeping its identity and continuing to provide best-in-class service to its customers. Silver Lake will thereby preserve Silae’s existing operating model, strengthen it further and make its offering even more accessible to customers.
Financial terms of the transaction were not disclosed. The transaction is expected to close in the third quarter subject to regulatory approval.
About Silae
Founded in 2010 and headquartered in Aix-en-Provence, France, Silae is a provider of cloud-based Payroll and HR software, offering a broad range of solutions to more than 550,000 businesses in partnership with its strong network of CPA and HR outsourcing partners. The company’s core SaaS product line Silaexpert enables full automation of complex payroll and HR processes, ensuring full adherence with constantly evolving labour and tax regulations in France and facilitating seamless communication and data exchange between outsourcing partners and customers in a highly collaborative environment. For more information, please visit silaexpert.fr.
About Silver Lake
Silver Lake is a global technology investment firm, with over $40 billion in combined assets under management and committed capital and a team of approximately 100 investment and operating professionals located in Silicon Valley, New York, London and Hong Kong. Silver Lake’s portfolio of investments collectively generates more than $230 billion of revenue annually and employs 370,000 people globally. For more information about Silver Lake and its portfolio, please visit silverlake.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200707005948/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
2PointZero Group Signals Global Scale With Revenue Surge to AED 21.9 Billion and Net Profit of AED 7.7 Billion in H1 202631.7.2026 13:42:00 CEST | Press release
Group revenue growth supported by stable gross profit margin of 29%, and adjusted EBITDA of AED 5.0 billionGlobal expansion milestones include the completed sale of TAQA stake, and the acquisition of Traverse Midstream Partners in North America, Baobab Group in Africa, and 60.8% of ISEM in ItalyTIME ranks the Group 36th on the World’s Growth Leaders list for 2026, highlighting market stability, operational scale and disciplined approach to capital 2PointZero Group (ADX: 2POINTZERO), a leading Abu Dhabi-based investment holding firm, announced its financial results for the first half of 2026, reporting revenue of AED 21.9 billion and delivering a Group Net Profit of AED 7.7 billion. This robust performance is reflected in the Group’s adjusted EBITDA, which reached AED 5.0 billion after excluding fair value changes and one-offs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260731538982/en/ Samia Bouazza, CEO of 2PointZero (P
Datroway® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy31.7.2026 08:30:00 CEST | Press release
Approval based on TROPION-Breast02 phase 3 trial results where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival Datroway now approved for two breast cancer indications in the EU Datroway® (datopotamab deruxtecan) has been approved in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinionof the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on result
Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate31.7.2026 08:30:00 CEST | Press release
Polpharma Biologics International AG today announces that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted for review the Biologics License Application (BLA) and Marketing Authorisation Application (MAA), respectively, for PB016, a proposed vedolizumab biosimilar candidate to Takeda’s reference product Entyvio®* (vedolizumab) lyophilized vial for intravenous (IV) administration for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease. The BLA and MAA acceptances represent significant milestones in Polpharma Biologics' development program and underscore the company's commitment to advancing high-quality biosimilars and expanding global access to affordable biologic medicines. "FDA and EMA acceptances for review of our IV vedolizumab biosimilar candidate mark a major achievement for Polpharma Biologics and validate our deep scientific expertise in biosimilar development and manufacturing," said
SES: Disclosure of Share Buyback Transactions31.7.2026 07:30:00 CEST | Press release
In the time period from June 2, 2026 until and including June 23, 2026, a number of 213,167 shares were bought back within the framework of the share buyback of SES to meet obligations under SES’s Equity Based Compensation Plan (EBCP). Shares were bought back as follows: Day of purchase Aggregated volume in shares Daily weighted average acquisition price of shares (EUR) Market June 2, 2026 27,097 8.8727 DXE June 2, 2026 72,903 8.8556 ENX June 5, 2026 16,624 8.3723 DXE June 5, 2026 31,510 8.4266 ENX June 15, 2026 26,451 7.8423 XPAR June 17, 2026 26,812 7.3910 XPAR June 23, 2026 11,770 7.2200 XPAR The transactions in a detailed form are published on SES’s website: https://www.ses.com/investors/shareholder-information/share-buy-backs. Follow us on: Twitter | Facebook | YouTube | LinkedIn | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, busin
Half-Year Report on SES’s Liquidity Contract31.7.2026 07:30:00 CEST | Press release
Pursuant to the liquidity contract entered into by SES with BNP Paribas as of 7 April 2026, please see the below update on the progress of the liquidity services. When the liquidity services were implemented as of 7 April 2026, the following assets were in the liquidity account: € 2,500,000 As of 30 June 2026, the following assets appeared on the liquidity account: 228,186 shares; € 816,880. Over the period from 7 April 2026 to 30 June 2026, the following transactions were executed: 1,082 buy transactions; 1,308 sales transactions. Over this same period, the volumes traded represented: 1,093,335 shares and € 8,485,986 on the buy side; 873,399 shares and € 6,860,843 on the sell side. Follow us on: LinkedIn | Facebook | YouTube | X | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, businesses grow, and people stay connected—no matter where th
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
